Literature DB >> 23359295

Vitamin D: metabolism, molecular mechanisms, and mutations to malignancies.

Natalie Nemazannikova1, Kiriakos Antonas, Crispin R Dass.   

Abstract

The potential protective effects of vitamin D against cutaneous carcinogenesis are still poorly understood. The inhibition, by vitamin D, of various cancers in in vitro and in vivo models has triggered detailed investigation of vitamin D effects on neoplastic behavior. Recent studies highlight that such neoplastic features as the tumor microenvironment, angiogenesis, DNA mutagenesis, and apoptosis are all connected to vitamin D metabolic pathways. This review discusses these connections. Vitamin D modulation of the cell cycle, DNA repair and apoptosis via its receptors (VDRs) may have a suppressive effect on skin cancer as some studies suggest. The regulation of multiple tumor signaling pathways by vitamin D may have an implication in cutaneous carcinogenesis and tumor progression to malignancy.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  NMSC; angiogenesis; cancer; tumor; vitamin D

Mesh:

Substances:

Year:  2013        PMID: 23359295     DOI: 10.1002/mc.21999

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

1.  Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.

Authors:  Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum
Journal:  Nutr Cancer       Date:  2015-08-28       Impact factor: 2.900

2.  Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Su-Chun Cheng; Tianxi Cai; Andrew Cagan; Vivian S Gainer; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-23       Impact factor: 11.382

3.  Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients.

Authors:  Mustafa Sahin; Bekir Uçan; Zeynep Giniş; Oya Topaloğlu; Aşkın Güngüneş; Nujen Çolak Bozkurt; Müyesser Sayki Arslan; İlknur Öztürk Ünsal; Esra Tutal Akkaymak; Taner Demirci; Melia Karaköse; Mustafa Çalışkan; Erman Çakal; Mustafa Özbek; Tuncay Delibaşı
Journal:  Med Oncol       Date:  2013-05-05       Impact factor: 3.064

4.  Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer.

Authors:  Teresa Granato; Lucia Manganaro; Luca Petri; Maria Grazia Porpora; Valentina Viggiani; Antonio Angeloni; Emanuela Anastasi
Journal:  Tumour Biol       Date:  2015-09-09

5.  1,25-Dihydroxyvitamin D3 modulates calcium transport in goat mammary epithelial cells in a dose- and energy-dependent manner.

Authors:  Feifei Sun; Yangchun Cao; Chao Yu; Xiaoshi Wei; Junhu Yao
Journal:  J Anim Sci Biotechnol       Date:  2016-07-28

6.  Gender differences and typical nutrition concerns of the diets of preschool children - the results of the first stage of an intervention study.

Authors:  Sylwia Merkiel-Pawłowska; Wojciech Chalcarz
Journal:  BMC Pediatr       Date:  2017-12-19       Impact factor: 2.125

7.  Evaluation of vitamin D3 levels and morphotic parameters of blood in prematurely born children at six years of age.

Authors:  Katarzyna Walicka-Cupryś; Katarzyna Zajkiewicz; Justyna Drzał-Grabiec; Lidia Perenc
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

8.  Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.

Authors:  C Brosseau; C Dousset; C Touzeau; S Maïga; P Moreau; M Amiot; S Le Gouill; C Pellat-Deceunynck
Journal:  Cell Death Dis       Date:  2014-08-28       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.